Masashi Nakamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Masashi Nakamura has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Kayoko Matsunaga
Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
10 shared publications - Akiko Yagami
Collaborative Department of Advanced Allergy and Immunology Fujita Health University School of Medicine Nagoya Japan
6 shared publications - Komei Ito
Department of Allergy, Allergy and Immunology Center Aichi Children's Health and Medical Center Obu Japan
6 shared publications - Teruaki Matsui
Department of Allergy, Allergy and Immunology Center Aichi Children's Health and Medical Center Obu Japan
5 shared publications - Nayu Sato
Collaborative Department of Advanced Allergy and Immunology, Fujita Health University School of Medicine, Toyoake, Japan
4 shared publications - Katsumasa Kitamura
Department of Allergy, Allergy and Immunology Center Aichi Children's Health and Medical Center Obu Japan
3 shared publications
Latest Publications
- Open Access
- 17 August 2026
- Published by Wolters Kluwer Health in Asia Pacific Allergy
A case of systemic peach allergy without sensitization to gibberellin-regulated protein and lipid-transfer protein: identification of FKBP20-1 as a potential allergen
Peach allergy is a common plant food allergy; specifically, sensitization to gibberellin-regulated protein (GRP; Pru p 7) and lipid-transfer protein (LTP; Pru p 3) is considered a predictor of severe allergic reactions in patients with peach allergy. However, the allergenic mechanisms in patients who are negative for these components remain unclear. Herein, we report the case of a 26-year-old Japanese man with a history of atopic dermatitis and pollinosis. The patient developed systemic allergic symptoms, including oral pruritus, pharyngeal swelling, respiratory discomfort, palpitations, and pallor, after ingesting a whole raw peach. Specific immunoglobulin E (IgE) to peach extract and Pru p 1 was positive, whereas specific IgE to Pru p 3, Pru p 4, and Pru p 7 was negative. Skin prick testing was positive for raw peach but negative for purified peach GRP. A proteomic approach was used to identify causative allergens. Two-dimensional electrophoresis and immunoblotting revealed an IgE-binding protein spot at approximately 25 kDa. Mass spectrometry identified the protein as peptidyl-prolyl cis-trans isomerase FKBP20-1 (FKBP20-1). Recombinant FKBP20-1 showed strong IgE reactivity with the patient’s serum but not with sera from nonallergic controls. Therefore, FKBP20-1 may represent a potential IgE-binding allergen involved in systemic reactions to peaches in patients who are not sensitized to GRP or LTP. Further studies are needed to clarify the clinical relevance of these findings.
- 17 August 2026
- Published by Wolters Kluwer Health in Asia Pacific Allergy
Open AccessA case of systemic peach allergy without sensitization to gibberellin-regulated protein and lipid-transfer protein: identification of FKBP20-1 as a potential allergen
Peach allergy is a common plant food allergy; specifically, sensitization to gibberellin-regulated protein (GRP; Pru p 7) and lipid-transfer protein (LTP; Pru p 3) is considered a predictor of severe allergic reactions in patients with peach allergy. However, the allergenic mechanisms in patients who are negative for these components remain unclear. Herein, we report the case of a 26-year-old Japanese man with a history of atopic dermatitis and pollinosis. The patient developed systemic allergic symptoms, including oral pruritus, pharyngeal swelling, respiratory discomfort, palpitations, and pallor, after ingesting a whole raw peach. Specific immunoglobulin E (IgE) to peach extract and Pru p 1 was positive, whereas specific IgE to Pru p 3, Pru p 4, and Pru p 7 was negative. Skin prick testing was positive for raw peach but negative for purified peach GRP. A proteomic approach was used to identify causative allergens. Two-dimensional electrophoresis and immunoblotting revealed an IgE-binding protein spot at approximately 25 kDa. Mass spectrometry identified the protein as peptidyl-prolyl cis-trans isomerase FKBP20-1 (FKBP20-1). Recombinant FKBP20-1 showed strong IgE reactivity with the patient’s serum but not with sera from nonallergic controls. Therefore, FKBP20-1 may represent a potential IgE-binding allergen involved in systemic reactions to peaches in patients who are not sensitized to GRP or LTP. Further studies are needed to clarify the clinical relevance of these findings.
- 2 February 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (2) , e70291
Proteomic approach to investigate allergens involved in severe walnut allergy
Background: Despite the increasing prevalence of walnut allergy (WA), no allergen components have been established as markers of disease severity. This study aimed to identify proteins specifically associated with severe WA in children. Methods: We analyzed 48 children aged 3.4–16 years who underwent an oral food challenge to walnut between February 2019 and March 2022. Children with positive and negative reactions were categorized into a WA group and walnut sensitization (WS) group, respectively. The dose‐adjusted reaction severity of WA patients was quantified using the Anaphylaxis Scoring Aichi's total score divided by the cumulative protein dose that induced symptoms (TS/Pro). Using the median TS/Pro value in all cases of the WA group as a cut‐off, 11 of 21 WA patients with stored sera were classified as high TS/Pro (TS/Pro ≥154.1); the remaining 10 patients were classified as low TS/Pro. Immunoblotting, mass spectrometry, and enzyme‐linked immunosorbent assay (ELISA) were used to identify candidate markers of WA severity. Results: Jug r 1‐specific IgE (sIgE) levels were higher in the WA group, but were not significantly associated with TS/Pro. Immunoblotting and mass spectrometry detected phospholipase D alpha 1 (PLDa1) in 5/11 (45.5%) high TS/Pro patients and 1/10 (10%) low TS/Pro patients ( p = .149). ELISA with recombinant PLDa1 confirmed similar results. Moreover, the absorbance of recombinant PLDa1‐sIgE was significantly correlated with TS/Pro ( ρ = 0.47, p = .032). Conclusions: PLDa1 (Jug r 9) is a candidate marker of WA severity. The early identification of children at risk of severe WA may aid clinicians in optimizing their management strategies.
- 2 February 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (2) , e70291
Proteomic approach to investigate allergens involved in severe walnut allergy
Background: Despite the increasing prevalence of walnut allergy (WA), no allergen components have been established as markers of disease severity. This study aimed to identify proteins specifically associated with severe WA in children. Methods: We analyzed 48 children aged 3.4–16 years who underwent an oral food challenge to walnut between February 2019 and March 2022. Children with positive and negative reactions were categorized into a WA group and walnut sensitization (WS) group, respectively. The dose‐adjusted reaction severity of WA patients was quantified using the Anaphylaxis Scoring Aichi's total score divided by the cumulative protein dose that induced symptoms (TS/Pro). Using the median TS/Pro value in all cases of the WA group as a cut‐off, 11 of 21 WA patients with stored sera were classified as high TS/Pro (TS/Pro ≥154.1); the remaining 10 patients were classified as low TS/Pro. Immunoblotting, mass spectrometry, and enzyme‐linked immunosorbent assay (ELISA) were used to identify candidate markers of WA severity. Results: Jug r 1‐specific IgE (sIgE) levels were higher in the WA group, but were not significantly associated with TS/Pro. Immunoblotting and mass spectrometry detected phospholipase D alpha 1 (PLDa1) in 5/11 (45.5%) high TS/Pro patients and 1/10 (10%) low TS/Pro patients ( p = .149). ELISA with recombinant PLDa1 confirmed similar results. Moreover, the absorbance of recombinant PLDa1‐sIgE was significantly correlated with TS/Pro ( ρ = 0.47, p = .032). Conclusions: PLDa1 (Jug r 9) is a candidate marker of WA severity. The early identification of children at risk of severe WA may aid clinicians in optimizing their management strategies.
- Open Access
- 14 January 2026
- Published by Wolters Kluwer Health in Asia Pacific Allergy
- Vol. 16 (4) , 240-243
Anaphylaxis caused by mustard in children: A case report from Japan
Despite reports in Western countries, mustard allergy is rarely acknowledged in Japan. Here, we present the case of a 4-year-old girl without previous allergies who developed anaphylaxis after eating a hot dog containing mustard and required intramuscular epinephrine administration. ImmunoCAP testing revealed mustard-specific immunoglobulin E (6.72 kUA/L), and the skin prick test was strongly positive to yellow mustard, oriental mustard, and processed mustard products. Oral food challenge (OFC) with 10 mg mustard (approximately 0.4 mg mustard protein) provoked vomiting. Therefore, she was diagnosed with mustard allergy. Two-dimensional western blot analysis and mass spectrometry led to the identification of 12 proteins from 10 immunoglobulin E (IgE)-binding spots; however, none corresponded to known mustard allergens (Sin a 1–4). Notably, spot 7 exhibited significant IgE-binding but remained unidentified, suggesting potential novel allergens. This is the first documented case of mustard allergy in Japan verified with OFC, highlighting both the risk of severe reactions at minimal doses and the importance of OFC for diagnosis. Further studies using recombinant allergens are warranted to validate the clinical relevance of the newly identified proteins in the present case.
- 14 January 2026
- Published by Wolters Kluwer Health in Asia Pacific Allergy
- Vol. 16 (4) , 240-243
Open AccessAnaphylaxis caused by mustard in children: A case report from Japan
Despite reports in Western countries, mustard allergy is rarely acknowledged in Japan. Here, we present the case of a 4-year-old girl without previous allergies who developed anaphylaxis after eating a hot dog containing mustard and required intramuscular epinephrine administration. ImmunoCAP testing revealed mustard-specific immunoglobulin E (6.72 kUA/L), and the skin prick test was strongly positive to yellow mustard, oriental mustard, and processed mustard products. Oral food challenge (OFC) with 10 mg mustard (approximately 0.4 mg mustard protein) provoked vomiting. Therefore, she was diagnosed with mustard allergy. Two-dimensional western blot analysis and mass spectrometry led to the identification of 12 proteins from 10 immunoglobulin E (IgE)-binding spots; however, none corresponded to known mustard allergens (Sin a 1–4). Notably, spot 7 exhibited significant IgE-binding but remained unidentified, suggesting potential novel allergens. This is the first documented case of mustard allergy in Japan verified with OFC, highlighting both the risk of severe reactions at minimal doses and the importance of OFC for diagnosis. Further studies using recombinant allergens are warranted to validate the clinical relevance of the newly identified proteins in the present case.
- 10 December 2025
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 36 (12) , e70254
Exploration of severity‐associated peanut allergens via proteomic analysis
Background: The relationship between the severity of peanut allergy and component‐specific immunoglobulin E (IgE) remains partially analyzed. We aimed to explore this relationship using a proteomic analysis of pediatric patients with peanut allergy. Methods: Immunoblotting and mass spectrometry were used to identify candidate peanut allergen components, which were confirmed via enzyme‐linked immunosorbent assay using sera from pediatric patients with peanut allergy confirmed through a positive oral food challenge test (OFC). The association between each protein‐specific IgE level and the severity of peanut allergy was compared. The severity of peanut allergy was quantified as TS/Pro, which is the total score (TS) of Anaphylaxis Scoring Aichi divided by the cumulative protein dose of peanuts at the OFC (Pro). Results: This study comprised 52 patients with peanut allergy. In addition to the known peanut allergen components, we discovered seven allergens in more than five participants. Among the participants, 24 (46.2%) had Annexin Gh1‐specific IgE. Ara h 2 ( r s = 0.67, p < .001) and Ara h 6 ( r s = 0.66, p < .001) specific IgEs and the sum of the absorbance of all seven candidates ( r s = 0.64, p < .001) were strongly correlated with TS/Pro. Ara h 1 ( r s = 0.30, p < .05), Ara h 3 (rs = 0.37, p < .01), Ara h 7 ( r s = 0.34, p < .05), and the seed biotin‐containing protein SBP65 ( r s = 0.35, p < .05) specific IgEs were correlated with TS/Pro. Conclusion: Ara h 2‐ and 6‐specific IgEs and sensitization diversity were the most significant factors that correlated with peanut allergy severity. We identified SBP65 (Ara h 20) as a potential novel allergen component related to peanut allergy severity.
- 10 December 2025
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 36 (12) , e70254
Exploration of severity‐associated peanut allergens via proteomic analysis
Background: The relationship between the severity of peanut allergy and component‐specific immunoglobulin E (IgE) remains partially analyzed. We aimed to explore this relationship using a proteomic analysis of pediatric patients with peanut allergy. Methods: Immunoblotting and mass spectrometry were used to identify candidate peanut allergen components, which were confirmed via enzyme‐linked immunosorbent assay using sera from pediatric patients with peanut allergy confirmed through a positive oral food challenge test (OFC). The association between each protein‐specific IgE level and the severity of peanut allergy was compared. The severity of peanut allergy was quantified as TS/Pro, which is the total score (TS) of Anaphylaxis Scoring Aichi divided by the cumulative protein dose of peanuts at the OFC (Pro). Results: This study comprised 52 patients with peanut allergy. In addition to the known peanut allergen components, we discovered seven allergens in more than five participants. Among the participants, 24 (46.2%) had Annexin Gh1‐specific IgE. Ara h 2 ( r s = 0.67, p < .001) and Ara h 6 ( r s = 0.66, p < .001) specific IgEs and the sum of the absorbance of all seven candidates ( r s = 0.64, p < .001) were strongly correlated with TS/Pro. Ara h 1 ( r s = 0.30, p < .05), Ara h 3 (rs = 0.37, p < .01), Ara h 7 ( r s = 0.34, p < .05), and the seed biotin‐containing protein SBP65 ( r s = 0.35, p < .05) specific IgEs were correlated with TS/Pro. Conclusion: Ara h 2‐ and 6‐specific IgEs and sensitization diversity were the most significant factors that correlated with peanut allergy severity. We identified SBP65 (Ara h 20) as a potential novel allergen component related to peanut allergy severity.
- Open Access
- 9 October 2023
- Published by Wolters Kluwer Health in Asia Pacific Allergy
- Vol. 13 (4) , 201-204
A case of white bean allergy
White bean allergy is uncommon and rarely reported. Herein, we report a case of white bean allergy in a patient with Down syndrome. A 7-year-old girl with Down syndrome experienced allergic symptoms twice after eating white bean and visited our hospital for a food allergy investigation. An ImmunoCAP assay revealed a white bean-specific IgE (13.4 kUA/L) in the patient’s serum. In addition, her skin prick test result was positive. Moreover, ingestion of 2 g of boiled white beans in an oral food challenge test induced intermittent cough, desaturation, generalized urticaria, abnormal sleep, and mild hypotension. Thus, we diagnosed the patient with white bean allergy. We performed western blotting and mass spectrometric analysis and detected the following allergens: Phytohemagglutinin, group 3 late embryogenesis abundant protein, lipoxygenase, and legumin. In addition, we detected several candidate allergenic proteins for the first time. White bean, runner bean, or azuki bean was considered the primary source of sensitization because although immunoblotting inhibition tests revealed that the abovementioned beans inhibited other legumes, soybean, which she tolerates, showed little inhibition of the other legumes. However, we could not confirm whether the patient could ingest legumes other than soybean or white bean because her family did not wish to continue with further testing. This is the first report of a case of systemic allergic reactions to white bean in a child with Down syndrome. Further studies are needed to identify white bean allergens and understand the relationship between Down syndrome and white bean allergy.
- 9 October 2023
- Published by Wolters Kluwer Health in Asia Pacific Allergy
- Vol. 13 (4) , 201-204
Open AccessA case of white bean allergy
White bean allergy is uncommon and rarely reported. Herein, we report a case of white bean allergy in a patient with Down syndrome. A 7-year-old girl with Down syndrome experienced allergic symptoms twice after eating white bean and visited our hospital for a food allergy investigation. An ImmunoCAP assay revealed a white bean-specific IgE (13.4 kUA/L) in the patient’s serum. In addition, her skin prick test result was positive. Moreover, ingestion of 2 g of boiled white beans in an oral food challenge test induced intermittent cough, desaturation, generalized urticaria, abnormal sleep, and mild hypotension. Thus, we diagnosed the patient with white bean allergy. We performed western blotting and mass spectrometric analysis and detected the following allergens: Phytohemagglutinin, group 3 late embryogenesis abundant protein, lipoxygenase, and legumin. In addition, we detected several candidate allergenic proteins for the first time. White bean, runner bean, or azuki bean was considered the primary source of sensitization because although immunoblotting inhibition tests revealed that the abovementioned beans inhibited other legumes, soybean, which she tolerates, showed little inhibition of the other legumes. However, we could not confirm whether the patient could ingest legumes other than soybean or white bean because her family did not wish to continue with further testing. This is the first report of a case of systemic allergic reactions to white bean in a child with Down syndrome. Further studies are needed to identify white bean allergens and understand the relationship between Down syndrome and white bean allergy.
- Open Access
- 8 April 2023
- Published by Elsevier in Allergology International
- Vol. 72 (4) , 604-606
Allergic reaction to Hyperlasion Schmitz (Diptera: Sciaridae)
- 8 April 2023
- Published by Elsevier in Allergology International
- Vol. 72 (4) , 604-606
Open AccessAllergic reaction to Hyperlasion Schmitz (Diptera: Sciaridae)
- Open Access
- 12 December 2022
- Published by Elsevier in Allergology International
- Vol. 72 (2) , 279-285
Nattokinase (Bac s 1), a subtilisin family serine protease, is a novel allergen contained in the traditional Japanese fermented food natto
- 12 December 2022
- Published by Elsevier in Allergology International
- Vol. 72 (2) , 279-285
Open AccessNattokinase (Bac s 1), a subtilisin family serine protease, is a novel allergen contained in the traditional Japanese fermented food natto
- Open Access
- 28 June 2022
- Published by Elsevier in Allergology International
- Vol. 71 (4) , 505-511
The clinical cross-reactivity and immunological cross-antigenicity of wheat and barley
- 28 June 2022
- Published by Elsevier in Allergology International
- Vol. 71 (4) , 505-511
Open AccessThe clinical cross-reactivity and immunological cross-antigenicity of wheat and barley
- 1 January 2022
- Vol. 71 (2) , 135-139
[ANAPHYLACTIC REACTION TO LYSOZYME CHLORIDE-INCLUDING DEODORANT SPRAY IN A CHILD WITH EGG ALLERGY].
Lysozyme chloride is a bactericidal substance that is included as an active ingredient in many medicines and quasi-drugs. We experienced a case of anaphylactic reaction caused by deodorant spray-containing lysozyme chloride. The patient was a 10-year-old girl who had an egg allergy. She visited an emergency department because of urticaria, wheezing, dyspnea, and pallor after she used deodorant spray that contained lysozyme chloride derived from hen's egg white. Results for deodorant spray and lysozyme chloride were positive in both skin prick tests and basophil activation tests. According to the medical history and the results, her condition was diagnosed as an anaphylactic reaction to lysozyme chloride in the deodorant spray. Although ingredient labelling is obligatory for lysozyme chloride in quasi-drugs, lysozyme chloride is not often described to be derived from egg white. It is important to alert patients with egg allergy to avoid lysozyme chloride-containing products.
- 1 January 2022
- Vol. 71 (2) , 135-139
[ANAPHYLACTIC REACTION TO LYSOZYME CHLORIDE-INCLUDING DEODORANT SPRAY IN A CHILD WITH EGG ALLERGY].
Lysozyme chloride is a bactericidal substance that is included as an active ingredient in many medicines and quasi-drugs. We experienced a case of anaphylactic reaction caused by deodorant spray-containing lysozyme chloride. The patient was a 10-year-old girl who had an egg allergy. She visited an emergency department because of urticaria, wheezing, dyspnea, and pallor after she used deodorant spray that contained lysozyme chloride derived from hen's egg white. Results for deodorant spray and lysozyme chloride were positive in both skin prick tests and basophil activation tests. According to the medical history and the results, her condition was diagnosed as an anaphylactic reaction to lysozyme chloride in the deodorant spray. Although ingredient labelling is obligatory for lysozyme chloride in quasi-drugs, lysozyme chloride is not often described to be derived from egg white. It is important to alert patients with egg allergy to avoid lysozyme chloride-containing products.
- Open Access
- 1 July 2021
- Published by Elsevier in Allergology International
- Vol. 70 (3) , 382-385
Antigen analysis of patients with gastrointestinal symptoms resulting from immediate allergic reactions to mushrooms
- 1 July 2021
- Published by Elsevier in Allergology International
- Vol. 70 (3) , 382-385
Open AccessAntigen analysis of patients with gastrointestinal symptoms resulting from immediate allergic reactions to mushrooms